Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 22, 2020
Optimizing patient selection for treatment-free remissionCaitlin R Rausch, Shilpa PaulJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2018
Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicitiesCaitlin R Rausch, Dimitrios P KontoyiannisBritish Journal of Haematology|December 13, 2019
The face of remission inductionShilpa Paul, Caitlin R Rausch, Elias J JabbourMycoses|September 20, 2018
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patientsAdam J DiPippo, Caitlin R Rausch, Dimitrios P KontoyiannisClinical Lymphoma, Myeloma & Leukemia|March 5, 2023
SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New ApproachesCaitlin R Rausch, Hagop M Kantarjian, Elias J JabbourFuture Oncology (London, England)|August 5, 2017
Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicinShilpa Paul, Caitlin R Rausch, Hagop Kantarjian, et al.Expert Opinion on Emerging Drugs|November 9, 2020
Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trialsNadya Jammal, Caitlin R Rausch, Tapan M Kadia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2018
Breakthrough Fungal Infections in Patients With Leukemia Receiving IsavuconazoleCaitlin R Rausch, Adam J DiPippo, Prithviraj Bose, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
New antifungals for the treatment of invasive mold diseaseNancy N Vuong, David R McClung, Samuel L Aitken, et al.Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Treatment of relapsed/refractory acute lymphoblastic leukemiaShilpa Paul, Caitlin R Rausch, Patrice E Nasnas, et al.Pageof 4